The board of directors has, in accordance with the Company’s articles of association, resolved that the shareholders may exercise their voting rights at the general meeting by voting in advance, so-called postal voting. Shareholders may therefore choose to exercise their voting rights at the Annual General Meeting by physical participation, by proxy or by advance voting.

Right to participate in the Annual General Meeting and notification
Physical participation by presence at the Annual General Meeting
Shareholders who wish to attend the Annual General Meeting by physical presence in person or through a proxy must:
i. on the record date, which is Monday, 25 May 2026, be registered in the share register maintained by Euroclear Sweden AB; and
ii. notify the Company of their participation and any assistants (no more than two) in the Annual General Meeting no later than Wednesday, 27 May 2026 in accordance with the instructions below.

Notification of participation by presence at the Annual General Meeting shall be made to the Company by one of the following methods:
• By post: Cavotec Group AB, “Annual General Meeting”, c/o Euroclear Sweden AB, Box 191, 101 23 Stockholm, Sweden;
• By telephone: +46 8 402 91 33 (weekdays 09:00-16:00);
• By e-mail: generalmeetingservice@euroclear.com; or
• Through Euroclear Sweden AB’s website: https://www.euroclear.com/sweden/generalmeetings/.

The notification shall include the shareholder’s name, personal or corporate identification number, address and telephone number, and any assistants (no more than two).

Participation through advance voting
Shareholders wishing to attend the Annual General Meeting by advance voting, personally or by a proxy must:
i. on the record date, which is Monday, 25 May 2026, be registered in the share register maintained by Euroclear Sweden AB; and
ii. give notice by casting their advance vote in accordance with the instructions below so that the advance vote is received by the Company no later than Wednesday, 27 May 2026.

A special form shall be used for advance voting. The form is available on the Company’s website, www.cavotec.com. A shareholder who is exercising its voting right through advance voting does not need to notify the Company of its attendance to the Annual General Meeting. The advance voting form is considered as the notification of attendance to the Annual General Meeting.

The completed and signed form shall be sent to the Company in accordance with the following:
• By post: Cavotec Group AB, “Annual General Meeting”, c/o Euroclear Sweden AB, Box 191, 101 23 Stockholm, Sweden;
• By e-mail: generalmeetingservice@euroclear.com; or
• Through verification with BankID via Euroclear Sweden AB’s website, https://www.euroclear.com/sweden/generalmeetings/.

If the shareholder is a legal entity, a certificate of incorporation or a corresponding document shall be enclosed with the form. Authorisation documents shall also be attached for shareholders voting in advance by proxy. The shareholder may not provide special instructions or conditions in the voting form. If so, the vote is invalid.

Further instructions and conditions are included in the form for advance voting.

Nominee-registered shares
In order to be entitled to participate in the meeting, a shareholder whose shares have been registered in the name of a nominee must, in addition to registering for the meeting, register the shares in his/her own name so that the shareholder will be included in the presentation of the share register on Monday, 25 May 2026. Such registration may be temporary (so-called voting rights registration) and is requested from the nominee in accordance with the nominee’s routines in such time in advance as the nominee determines. Voting rights registration completed by the nominee no later than 27 May 2026 will be considered in the preparation of the share register.

Proxy etc.
Shareholders represented by proxy shall issue a dated and signed power of attorney to the proxy. If the power of attorney is issued by a legal entity, a copy of the certificate of registration, or equivalent authorisation documents, evidencing the authority to issue the power of attorney, shall be enclosed. The power of attorney may not be older than one year unless it states that it is valid for a longer period, not exceeding five years. To facilitate entry to the Annual General Meeting, a copy of the power of attorney and, where applicable, the certificate of registration should be submitted to the Company in accordance with the instructions above so that the documents are received by the Company no later than Wednesday, 27 May 2026. The power of attorney in original and, where applicable, the certificate of registration, shall be presented at the Annual General Meeting.

Proxy forms are available at the Company and on the Company’s website, www.cavotec.com, and will be sent by post to shareholders who so request and provide their postal address. 

Proposed agenda
1. Opening of the meeting.

2. Election of chair of the meeting.

3. Preparation and approval of the voting list.

4. Approval of the agenda.

5. Election of one or two persons to verify the minutes.

6. Presentation by the CEO.

7. Determination of whether the meeting has been duly convened.

8. Presentation of the annual report and the auditors’ report and the consolidated annual report and the consolidated auditor’s report.

9. Resolutions regarding:
a) adoption of the income statement and balance sheet and the consolidated income statement and the consolidated balance sheet;

b) allocation of profit or loss according to the adopted balance sheet; and

c) discharge from liability for the board members and the CEO.

10. Determination of the number of directors and auditors.

11. Determination of fees to the board of directors and auditor.

12. Election of the board of directors and auditor.

13. Resolution regarding approval of the remuneration report 2025.

14. Resolution regarding adoption of guidelines for remuneration to senior executives.

15. Resolution regarding (a) adoption of a long-term incentive program in the form of performance shares for employees (LTI 2026) and (b) hedging measures for LTI 2026:
(i) authorisation for the board of directors to resolve on the issue of redeemable and convertible C shares;
(ii) authorisation for the board of directors to resolve on the repurchase of all issued redeemable and convertible C shares;
(iii) transfer of own ordinary shares to participants in LTI 2026; and
(iv) authorisation for the board of directors to resolve on the transfer of own ordinary shares.

16. Resolution regarding authorisation for the board of directors to issue shares, warrants and/or convertibles.

17. Closing of the meeting.

PROPOSED RESOLUTIONS
Item 2: Election of chair of the meeting
The nomination committee of Cavotec, consisting of the chair Henrik Blomquist (Bure Equity AB) and the members Per Colleen (TomEnterprise Private AB), Thomas Ehlin (The Fourth Swedish National Pension Fund), Katarina Hammar (Nordea Funds) and Patrik Tigerschiöld (chairman of the board of directors of Cavotec), proposes that Patrik Tigerschiöld, or in his absence the person appointed by the board of directors in his stead, be elected as chair of the meeting.

Item 9(b): Resolution regarding allocation of profit or loss according to the adopted balance sheet
The board of directors proposes that the Annual General Meeting resolves that no dividend is paid for the financial year 2025 and that available funds shall be carried forward in the new accounts.

Items 10–12: Determination of the number of directors and auditors, determination of fees to the board of directors and auditor, and election of the board of directors and auditor
The nomination committee proposes that the board of directors shall consist of six directors. The nomination committee further proposes that the number of auditors shall be one registered audit firm.

The nomination committee proposes that board remuneration shall be paid with SEK 920,000 (previous year: EUR 85,000) to the chairman of the board of directors and with SEK 380,000 (EUR 35,000) to each of the other board members. It is furthermore proposed that remuneration for committee work shall be paid with SEK 125,000 (EUR 10,000) to the chairman of the audit committee, with SEK 70,000 (EUR 5,000) to each of the other members of the audit committee, with SEK 110,000 (EUR 10,000) to the chairman of the remuneration committee, and with SEK 55,000 (EUR 5,000) to each of the other members of the remuneration committee.

The nomination committee proposes that remuneration for the auditor shall be paid in accordance with approved invoice.

The nomination committee proposes that Niklas Edling, Annette Kumlien and Peter Nilsson be re-elected as board members and that Karin Falk, Keld Pedersen and Gösta Johannesson be elected as new board members until the end of the next Annual General Meeting. Furthermore, the nomination committee proposes that Niklas Edling be elected as new chair of the board of directors. It is noted that Patrik Tigerschiöld and Keith Svendsen have declined re-election.

Further information regarding the directors proposed for re-election is available on the Company’s website, www.cavotec.com.

Further information regarding the directors proposed for new election

Karin Falk
Born 1965. Swedish citizen, resident in Sweden.

Education: B.Sc. in Business Administration, School of Business, Economics and Law, University of Gothenburg, Sweden.

Current positions: President, Husqvarna Construction Division and Executive Vice President, Husqvarna Group.

Previous positions: Board member of Wärtsilä Corporation 2017–2026. Various positions within Volvo Group; Senior Vice President, Volvo Trucks Services & Customer Quality 2016–2020. Executive Vice President, Corporate Strategy & Brand Portfolio 2012–2016. President, Non-Automotive Purchasing 2008–2012. Various positions within Volvo Car Corporation; Vice President, Volvo Car Customer Service 2006–2008. President, Volvo Car Special Vehicles 2001–2006 and various positions within Volvo Cars and Volvo Group 1988–2001.

Own and related parties’ shareholding in the Company: –

Independence: Karin Falk is deemed to be independent in relation to the Company, company management and major shareholders.

Keld Pedersen
Born 1966. Danish citizen, resident in Morocco.

Education: Maritime education and extensive management training. Master Mariner certificate 1991 and diploma in economics and management 2005. Executive programme at London Business School, United Kingdom, and IMD, Switzerland, as well as various leadership and commercial training programmes 2000–2018.

Current positions: Head of APM Terminals’ Global Transshipment Hubs and Vice President, APM Terminals.

Previous positions: Leadership roles in global terminal operations, from officer and captain in the merchant navy to CEO positions in several countries, including Denmark, Malaysia, Sweden, India, Spain and Morocco, with responsibility for operations, technical departments and strategic management. Board positions in international terminal companies as joint venture and listed companies in a number of countries, reflecting his extensive experience in the port terminal sector.

Own and related parties’ shareholding in the Company: –

Independence: Keld Pedersen is deemed to be independent in relation to the Company, company management and major shareholders.

Gösta Johannesson
Born 1959. Swedish citizen, resident in Sweden.

Education: B.Sc. in Business Administration and Economics, Uppsala University, Sweden, and Advanced Management Program, Wharton School of the University of Pennsylvania, USA.

Current positions: Senior Advisor, Bure Equity AB. Chairman of Xvivo Perfusion Aktiebolag and board member of Yubico AB, Nodica Group AB and others.

Previous positions: Partner at Provider Venture Partners, and previously in senior positions at Öhman Fondkommission and Handelsbanken Markets.

Own and related parties’ shareholding in the Company: 6,000 shares.

Independence: Gösta Johannesson is deemed to be independent in relation to the Company and company management but not in relation to major shareholders.

The nomination committee proposes, in accordance with the audit committee’s recommendation, to re-elect the registered audit firm Öhrlings PricewaterhouseCoopers AB (“PwC”) as auditor for the period until the end of the next Annual General Meeting. PwC has informed that authorised auditor Patrik Adolfsson shall remain the auditor in charge if the meeting resolves in accordance with the proposal.

The nomination committee’s complete proposal and motivated statement are available on the Company’s website, www.cavotec.com.

Item 14: Resolution regarding adoption of guidelines for remuneration to senior executives
The board of directors of the Company proposes that the Annual General Meeting resolves to adopt the following guidelines for remuneration to senior executives.

General
The following guidelines for remuneration to senior executives shall apply to remuneration that has been agreed upon or to changes in already agreed remunerations after the guidelines have been adopted. The guidelines do not apply to remuneration specifically resolved by the general meeting.

These guidelines apply to the CEO and other senior executives in the group, as well as members of the board to the extent they are remunerated outside their board duties.

Regarding employment conditions that are governed by rules other than Swedish, appropriate adjustments may be made in order to comply with such mandatory rules or established local practice, whereby the general objectives of these guidelines shall, to the extent possible, be met.

The guidelines’ promotion of the Company’s business strategy, long-term interest and sustainability
The Company is a leading engineering company that designs and delivers connection and electrification solutions to enable the decarbonisation of ports and industrial applications. Based on 50 years of heritage in innovation and engineering expertise, the Company leverages its proven technology platforms and ability to deliver customised solutions that improve safety, efficiency, and sustainability. For more information regarding the Company’s business strategy, please see www.cavotec.com.

The guidelines shall contribute to establishing conditions for the Company to recognise and reward performance, enabling the Company to attract, motivate and retain talented employees who drive performance to ensure both sustained growth and value creation, and achieve its long-term interests, including sustainability. The guidelines shall also stimulate an increased interest in the business and the result as a whole as well as increase the motivation of the senior executives and increase belonging within the Company. The guidelines’ purpose is further to create alignment between the Company’s shareholders and the senior executives. The guidelines shall also contribute to good ethics and culture within the Company.

In order to achieve the Company’s business strategy, the total annual remuneration must be market-based and competitive in the employment market in which the senior executive is situated, as well as take into account the individual’s qualifications and experience; furthermore, exceptional performance should be reflected in the total remuneration.

The forms of remuneration etc.
The remuneration to the senior executives in the Company shall comprise of fixed base salary, possible variable cash compensation, other customary benefits and pension. In addition, the annual general meeting may – and independently of these guidelines – decide on share or share price-related remuneration. The total annual cash remuneration, including pension benefits, shall be in line with market practice and competitive on the labour market where the senior executive is based, and take into account the individual’s responsibilities, competences, qualifications and experiences as well as reflecting any notable achievements. Fixed base salary and variable cash remuneration shall be related to the senior executive’s responsibility and authority.

Long-term incentive plans are resolved upon by the general meeting and are thus excluded from these guidelines. For more information regarding the long-term incentive plans that are ongoing, or that have ended during the current year, please see the Company’s annual report and the Company’s website.

Fixed base salary
The fixed base salary for the CEO and other senior executives is reviewed annually and constitutes the foundation of total remuneration.

Variable cash compensation
The CEO, other senior executives and key employees may receive variable cash compensation in addition to fixed base salary through the Company’s annual short-term incentive plan (STIP).

Variable remuneration under the STIP is paid according to goals achieved for the Company as a whole and, where applicable, at division level. Payment of STIP remuneration is based on the outcome of a number of quantitative performance targets. The performance targets are determined by the board of directors at the beginning of each financial year and are defined in line with the year’s commitments, contribute to the long-term strategy and are aligned with business priorities, with the aim of achieving sustainable profitability. Remuneration under the STIP may amount to a maximum of 100 per cent of fixed annual base salary for the participants.

Other benefits
Pension benefits for the CEO and other senior executives shall reflect normal market conditions compared to what generally applies to corresponding senior executives in other companies and shall be in line with local market practice and legislation in the country where the senior executive is employed. At a minimum, pension benefits shall reflect the statutory requirements of the respective countries.

The Company may provide other benefits to senior executives in accordance with local practice. Such other benefits may include health insurance and car allowance.

Remuneration to board members
If a director performs services on behalf of the Company, which do not constitute board work, additional consultancy fees or other additional remuneration may be paid to directors upon decision by the board of directors following a recommendation by the remuneration committee. Any such remuneration shall be designed in accordance with these guidelines.

Termination of employment
Notice periods in the event of termination of employment may not exceed twelve months. No severance pay, other than salary and other benefits during the notice period, is paid. Fixed salary during the notice period shall not exceed an amount corresponding to a maximum of twelve months’ fixed salary.

Fixed salary during the notice period shall not exceed an amount corresponding to a maximum of twelve months’ fixed salary. The notice period for a senior executive may not exceed twelve months. In the event of termination by the executive, the notice period may not exceed six months. There is no right to severance pay.

Remuneration may be paid for non-compete undertakings. Such remuneration shall compensate for loss of income and shall only be paid to the extent the previously employed executive is not entitled to severance pay. The remuneration shall be based on the fixed cash salary at the time of termination of employment, unless otherwise provided by mandatory provisions in applicable collective agreements, and be paid during the time the non-compete undertaking applies, which shall not exceed twelve months after the termination of employment.

Deviations from the guidelines
The board of directors shall be entitled to deviate from the guidelines, in whole or in part, if in a specific case there is special cause for the deviation and a deviation is necessary to ensure the Company’s long-term interests and sustainability or to ensure the Company’s financial viability. Such deviation shall also be approved by the remuneration committee.

Preparation, decision processes etc.
Decisions regarding salary and other remuneration for the CEO and other senior executives are prepared by the remuneration committee and resolved by the board of directors and, where applicable, the CEO.

The remuneration committee shall also prepare the board of directors’ decisions on issues concerning principles for remuneration. The remuneration committee shall also monitor and evaluate programs for variable remuneration, both ongoing and those that have ended during the year, for the senior executives and monitor and evaluate the application of these guidelines for remuneration for senior executives, as well as current remuneration structures and levels in the Company.

In preparing the board of directors’ proposal for these guidelines, salary and terms of employment for the Company’s employees have been taken into account, with respect to information on the employees’ total remuneration, the components of the remuneration and the rate of increase and increase over time, when the remuneration committee and the board of directors have decided on the evaluation of the reasonableness of these guidelines and the limitations that follow from the guidelines.

The board of directors shall prepare a proposal for new guidelines at least every fourth year and submit it to the general meeting. The guidelines shall be in force until new guidelines are adopted by the general meeting.

Information regarding remuneration
For information on remuneration, please refer to the Company’s annual reports, which are available on the Company’s website.

Item 15: Resolution regarding (a) adoption of a long-term incentive program in the form of performance shares for employees (LTI 2026), and (b) hedging measures for LTI 2026
The board of directors of the Company proposes that the Annual General Meeting resolves on:
    (a) adoption of a long-term incentive program in the form of performance shares for the CEO, CMT and other senior key employees (“LTI 2026”); and

    (b) hedging measures for LTI 2026, consisting of:

        (i) authorisation for the board of directors to resolve on the issue of redeemable and convertible C shares;

        (ii) authorisation for the board of directors to resolve on the repurchase of all issued redeemable and convertible C shares;

        (iii) transfer of own ordinary shares to participants in LTI 2026; and

        (iv) authorisation for the board of directors to resolve on the transfer of own ordinary shares.

The proposals under items 15(a) and 15(b) shall be adopted as separate resolutions and are not conditional upon each other. Should the majority requirement under item 15(b) not be reached, the board of directors proposes that the Company, as part of the resolution under item 15(a), is entitled to enter into an equity swap agreement with a third party.

(a) Adoption of a long-term incentive program in the form of performance shares for employees (LTI 2026)

Background and purpose
The goal of LTI 2026 is to attract, engage, and retain key employees at Cavotec while aligning their interests with those of shareholders and the Company. LTI 2026 aims to foster shared objectives in achieving and exceeding the Company’s financial targets in the coming years.

LTI 2026 offers share awards that are granted based on the achievement of targets linked to the Company’s share price performance, encouraging participants to drive shareholder value. Additionally, it rewards employee loyalty, reinforcing Cavotec’s long-term value growth. The board of directors believes that LTI 2026 will positively influence Cavotec’s future growth by enabling key employees to increase their shareholding. This alignment of interests between employees, the Company, and shareholders is expected to drive long-term success.

Performance shares
Instruments under LTI 2026 (“Performance Shares”) will be granted free of charge entitling the participant, to receive a number of shares in Cavotec, free of charge, following a three-year vesting period (the “Vesting Period”) provided that the KPI set out below are met. For any allocation to occur, the participant must remain employed within Cavotec, unless the board of directors decides otherwise.

LTI 2026 will comprise up to the following number of Performance Shares for the individual participant within the categories below:
• Tier 1: CEO (1 employee) can, individually, be allocated a maximum of 300,000 Performance Shares.
• Tier 2: CMT (8 employees) can, individually, be allocated a maximum of 150,000 Performance Shares.
• Tier 3: Key Employees (18 employees) can, individually, be allocated a maximum of 40,000 Performance Shares.

Allocation of Performance Shares to participants will take place as soon as practicably possible following the Annual General Meeting 2026. The maximum number of Performance Shares under LTI 2026 that can be delivered to participants is 1,555,000. Future programs will be determined based on a thorough evaluation process, with no expectation that they will follow the same structure or size.

Terms and conditions
The allocation of Performance Shares depends on fulfilment of the KPI tied to Cavotec’s three-year total shareholder return (“Absolute TSR”). This will determine whether, and to what extent, participants are entitled to receive Cavotec shares at the end of the Vesting Period.

The start value for Absolute TSR will be calculated based on the volume-weighted average share price over 20 trading days following the release of the Q4 2025 report. The end value for TSR will be measured as the volume-weighted average share price over 20 trading days following the release of the Q4 2028 report. The measurement will include dividends paid during the period from the start to the end value (“Performance Period”).

If the Absolute TSR during the Performance Period reaches or exceeds an average annual growth rate of 12.5 per cent, the maximum vesting of 100 per cent of the Performance Shares will be allocated. If the Absolute TSR corresponds to an average annual growth rate of 7.5 per cent or lower, no vesting will occur. For Absolute TSR growth between 7.5 per cent and 12.5 per cent, the vesting of Performance Shares will be determined on a linear pro-rata basis, ranging from 0 per cent to 100 per cent.

Allocation and implementation
When determining the final vesting level of Performance Shares, the board of directors shall examine whether the vesting level is reasonable considering the Company’s financial results and position, conditions on the market and other circumstances, such as environmental, social ethics and compliance factors, and if not, as determined by the board of directors, reduce the vesting level to the lower level deemed appropriate by the board of directors.

In the event that delivery of shares to participants cannot take place under applicable law, or at reasonable cost or with reasonable administrative measures, the board of directors will be entitled to decide that participants may, instead, be offered a cash settlement.

The board of directors shall be responsible for the details of the agreements and conditions with participants, as well as the administration of LTI 2026. The Company is entitled to, prior to delivering vested shares to the participant, retain and sell the number of shares required to cover the cost for withholding and paying tax and social security liabilities on behalf of the participants in relation to the Performance Shares for remittance to the relevant tax authorities. In such case, vested shares will be delivered net to the participants after the vested Performance Shares are reduced by the number of shares retained by the Company for such purposes.

Hedging arrangements
The board of directors has evaluated different methods to secure the financial exposure and transfer of shares in accordance with LTI 2026, such as transfer of own shares and an equity swap agreement with a third party. The board of directors considers a directed issue of redeemable and convertible C shares and transfer of such shares to the participants (following conversion of the shares to ordinary shares) to be the most cost-effective and flexible method for hedging the financial exposure and transfer of shares under LTI 2026. The board of directors thus proposes that the main option to secure the financial exposure shall be transfer of own shares in accordance with the proposals set out under item 15(b) below, since the cost associated with an equity swap agreement vastly exceeds the costs of transferring own shares.

Should the majority required under item 15(b) below not be reached, the board of directors proposes that the Company shall, as part of the resolution under this item 15(a), be entitled to hedge the financial exposure of LTI 2026 by entering into an equity swap agreement with a third party on terms in accordance with market conditions, whereby the third party in its own name shall be entitled to acquire and transfer ordinary shares in the Company to the participants of LTI 2026.

Costs
The total impact of LTI 2026 on the income statement, assuming full allocation of Performance Shares, is estimated to be approximately SEK 15.16 million, distributed over 2026–2028. This estimate includes an assumed 20 per cent social security contribution cost, amounting to approximately SEK 5.8 million, based on the maximum achievement of all performance criteria, full allocation of Performance Shares, an initial share price of SEK 13.05 at the time of allocation, and a share price of SEK 18.58 after three years at the time of exercise. The costs will be recognized in accordance with IFRS 2 and will depend on the future development of Cavotec’s share price during the Vesting Period. The above calculations assume 0 per cent employee turnover during the Vesting Period.

Effects on dilution
At maximum allotment, including 1,555,000 Performance Shares and 311,000 shares for hedging social costs, the total dilution is approximately 1.72 per cent of Cavotec’s shares and votes.

Previous incentive programs in Cavotec
The Company currently has one outstanding long-term incentive program (LTI 2025). Further details on LTI 2025 can be found at www.cavotec.com.

(b) Hedging measures for LTI 2026
For the purpose of hedging the Company’s financial exposure, ensuring the delivery of shares, and securing the Company’s commitments under LTI 2026, including the hedging of obligations (such as costs for social security contributions), the board of directors proposes that the Annual General Meeting resolves on hedging measures in accordance with item 15(b)(i)–(iv) below. The proposals under item 15(b)(i)–(iv) shall be adopted as one resolution.

(i) Authorisation for the board of directors to resolve on the issue of redeemable and convertible C shares

The board of directors proposes that the Annual General Meeting resolves to authorise the board of directors, on one or more occasions prior to the next Annual General Meeting, and with deviation from the shareholders’ pre-emptive rights, to resolve on a new issue of redeemable and convertible C shares. For issues resolved pursuant to the authorisation, the following terms and conditions shall apply:

1. The number of C shares that may be issued shall amount to a maximum of 1,866,000.

2. The new C shares shall, with deviation from the shareholders’ pre-emptive rights, be subscribed for solely by a pre-arranged external party.

3. The amount payable for each new share shall correspond to the share’s quota value at the time of subscription.

4. The new C shares shall be subject to restrictions pursuant to Chapter 4, Section 6 (conversion clause) and Chapter 20, Section 31 (redemption clause) of the Swedish Companies Act.

(ii) Authorisation for the board of directors to resolve on the repurchase of all issued redeemable and convertible C shares

The board of directors proposes that the Annual General Meeting resolves to authorise the board of directors, on one or more occasions prior to the next Annual General Meeting, to resolve on the repurchase of all issued redeemable and convertible C shares in the Company on the following terms and conditions:

1. Repurchase may be effected through an offer directed to all holders of C shares in the Company.

2. Repurchase shall be made at the quota value applicable at the time of subscription pursuant to item 15(b)(i) above.

3. Payment for repurchased shares shall be made in cash.

4. The board of directors shall be entitled to determine the other terms and conditions of the repurchase.

5. Repurchase may also be made of so-called interim shares, designated by Euroclear Sweden AB as Paid Subscribed Shares (BTA), relating to C shares.

(iii) Transfer of own ordinary shares to participants in LTI 2026

The board of directors proposes that the Annual General Meeting resolves that a portion of the shares issued and repurchased in accordance with items 15(b)(i) and (ii) above, following conversion into ordinary shares, may be transferred to the participants under LTI 2026. Transfers of the Company’s own ordinary shares to participants in LTI 2026 may be made on the following terms and conditions:

1. Transfers may be made only of ordinary shares in the Company, whereby a maximum of 1,555,000 ordinary shares may be transferred free of charge to participants in LTI 2026.

2. The right to acquire ordinary shares in the Company free of charge shall, with deviation from the shareholders’ pre-emptive rights, vest in the participants in LTI 2026.

3. Transfers of ordinary shares in the Company shall be made free of charge at the time and on the other terms and conditions under which participants in LTI 2026 are entitled to be allotted shares.

4. The number of ordinary shares in the Company that may be transferred within the framework of LTI 2026 shall be subject to recalculation as a result of any intervening share split, reverse share split and/or other similar corporate actions.

(iv) Authorisation for the board of directors to resolve on the transfer of own ordinary shares

The board of directors proposes that the Annual General Meeting resolves to authorise the board of directors, on one or more occasions prior to the next Annual General Meeting, to resolve on the transfer of own shares on the following terms and conditions:

1. Transfers may be made of a maximum of 311,000 ordinary shares.

2. The shares may be transferred on Nasdaq Stockholm.

3. Transfers of shares on Nasdaq Stockholm may only be made at a price per share within the prevailing price range at the relevant time.

4. Payment for the shares shall be made in cash.

Item 16: Resolution regarding authorisation for the board of directors to issue shares, warrants and/or convertibles
The board of directors of the Company proposes that the Annual General Meeting resolves to authorise the board of directors during the period up until the next Annual General Meeting, on one or more occasions, to resolve on new issues of ordinary shares, warrants and/or convertibles, with or without deviation from the shareholders’ preferential right. The total number of shares that may be issued, by way of a new share issue, exercise of warrants or conversion of convertibles, by virtue of the authorisation shall not exceed ten (10) per cent of the total number of shares in the Company at the time of the Annual General Meeting. The authorisation includes a right to resolve on new issues for cash consideration, by contribution in kind or payment by set-off. The issue price shall, in the case of deviation from the shareholders’ preferential right, be determined in accordance with market practice.

The purpose of the authorisation, and the reason for any deviation from the shareholders’ preferential right, is to increase the financial flexibility of the Company to enable the Company to finance the operations in a fast and efficient way, acquire companies, businesses or parts thereof and/or to enable a broadening of the ownership of the Company.

The board of directors or anyone appointed by the board of directors shall be authorised to make such minor adjustments to the above resolution as may be required in connection with the registration with the Swedish Companies Registration Office.

Majority
A valid resolution under item 15(a) requires a simple majority of the votes cast.

A valid resolution under item 15(b) requires that the resolution is supported by shareholders representing at least nine-tenths of both the votes cast and the shares represented at the meeting.

A valid resolution under item 16 requires that the resolution is supported by shareholders representing at least two-thirds of both the votes cast and the shares represented at the meeting.

Number of shares and votes
As of the date of this notice, the total number of shares in the Company amounts to 106,696,030, all of which are ordinary shares carrying one vote per share. The total number of votes amounts to 106,696,030. The Company holds no treasury shares.

Other
Accounting documents, audit report and other documents for the Annual General Meeting will be made available at the Company at Vasagatan 11 in Stockholm and on the Company’s website, www.cavotec.com, no later than three weeks before the meeting. Copies of the documents will be sent by post to shareholders who so request and state their postal address.

The shareholders are hereby notified of their right to, at the Annual General Meeting, request information from the board of directors and the managing director according to Chapter 7, Section 32 of the Swedish Companies Act.

Processing of personal data
For information on how personal data is processed in relation to the meeting, see the privacy notice available on Euroclear Sweden AB’s website: https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.

______________________

Stockholm, April 2026
Cavotec Group AB
The Board of Directors